Pacific Biosciences of California (PACB) ended the recent trading session at $1.18, demonstrating a +1.72% change from the preceding day's closing price. This move outpaced the S&P 500's daily gain of 0.38%. Elsewhere, the Dow saw an upswing of 0.24%, while the tech-heavy Nasdaq appreciated by 0.24%. Coming into today, shares of the maker of genetic analysis technology had gained 5.45% in the past month. In that same time, the Medical sector gained 4.64%, while the S&P 500 gained 6.6%. Market participants w ...